If the initiative is approved, Massachusetts would be the third state in the U.S., after Oregon and Washington, to allow the measure, according to the report.
The measure would allow patients with less than six months to live to receive a dose of lethal medication from their physicians.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
